PharmiWeb.com - Global Pharma News & Resources
04-Feb-2021

Molecular Diagnostics Market 2020 Global Opportunities and Industry Share Expected Surpass US$ 20,673.2 Million by 2025 – Latest Application Development Insights

Global Molecular Diagnostics Market, by Product Type (Reagents & Kits and Instruments), by Application (Oncology, Genetic Testing, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, and Others), and by End User (Hospitals, Diagnostic Laboratories, Academic and Research Labs, and Others) is estimated to be valued at US$ 8,623.2 million in 2017 and is expected to exhibit a CAGR of 11.5% over the forecast period (2017-2025).

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1545

Global Molecular Diagnostics Market – Global Industry Insights

Molecular diagnostic is a collection of techniques, which is used analyze biological markers proteome and genome, which could be associated with disorders. The disturbance between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others factors lead to various diseases. Several diseases are diagnosed by using molecular diagnostic test such as infectious diseases, oncology, virology, and STDs.

Molecular diagnostics is used to identify specific disease, which helps to improve the medication and treatment. Various economies worldwide are focused on research and development activities of precision medicine, which is expected to drive growth of the global molecular diagnostics market during the forecast period. For instance, in 2015, the U.S. government introduced Precision Medicine Initiative (PMI) to increase awareness about advancement in the precision medicine field.

High prevalence of infectious diseases and increasing incidences of cancer are expected drive the market growth over forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, around 5,251 deaths were reported due to influenza infection in the U.S. Moreover, according to a National Cancer Institute, in 2016, around 16.8 million new cases of cancer were reported in the U.S. and around 595,690 deaths were reported from the disease. According to the same source, the number of people with cancer is expected to rise to 19 million by 2024.

The global molecular diagnostics market is estimated to be valued at US$ 8,623.2 Mn in 2017 and is expected to exhibit a CAGR of 11.5% during the forecast period (2017-2025).

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1545

Molecular Diagnostics Market Share, By Product Type (%)

Source: Coherent Market Insights (2018)

Growth in biomarker identification is expected to boost growth of the global molecular diagnostics market

Application of biomarkers in molecular diagnostic is increasing, owing to various advantages provided by biomarkers such as aiding in early detection of specific diseases. For instance, biomarkers are used in detection of ABO haemolytic diseases in newborn, Huntington’s disease and hereditary haemochromatosis, and cystic fibrosis. Biomarkers also find applications in detection of disorders related to chromosome structure such as Turner syndrome, Patau Syndrome, Down syndrome, and Edwards’s syndrome. Moreover, biomarker find applications in therapeutic areas, which includes neurological diseases, immune deregulation, metabolic disorders, and oncology.

Growing research and development activities for detection of biomarkers has led to development of new molecular diagnostic tests, which is expected to develop growth of the global molecular diagnostics market. For instance, in February 2018, Banyan Biomarkes, Inc. received the U.S. Food and Drug Administration (FDA) marketing authorization for the first diagnostic blood test indicated for traumatic brain injury, Banyan BTI. Such novel tests for various disease indications is expected to boost the global molecular diagnostics market growth in the near future.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/molecular-diagnostics-market-to-surpass-us-206732-million-by-2025-851

Regional insights

North America holds for the largest share in the global molecular diagnostics market. This is owing to increasing adoption of precision medicine and growing prevalence of cancer in the region. For instance, according to the National Cancer Institute, in 2016, around 16.8 million new cases of cancer were reported in the U.S. with around 595,690 deaths from the disease. According to the same source, the number of people with cancer is expected to reach to 19 million by 2024, which is expected to drive the global molecular diagnostics market in the near future.

Furthermore, in 2015, the U.S. government introduced Precision Medicine Initiative, which is aimed to enhance the treatment to improve health, as precision medicine provides novel approach that considers a patient’s differences in genes and offers custom-made treatment. Furthermore, Precision Medicine Initiative has led to manufacturing of innovative products and several new treatments that are tailored for specific characteristic such as, person’s genetic makeup or genetic profile of an individual tumor that helps to augment the way of treatment. In 2016, Precision Medicine Initiative was valued at US$ 215 million and could boost biomedical research and offer clinicians with new tools to select the innovative therapies developed according to an individual’s needs, which in turn, is expected to support growth of the global molecular diagnostic market.

Key players in the market focused on various growth strategies such as new product launches to cater increasing demand for molecular diagnostic. For instance, in August 2016 Abbott Laboratories launched Alinity, a next generation system, used for immunoassay, clinical chemistry, point-of-care, hematology, blood and plasma screening, and molecular diagnostics.

Major companies operating in the global molecular diagnostics market include Hologic, Inc., Grifols, S.A., Abbott Laboratories, Qiagen N.V., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, and Beckman Coulter, Inc.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1545

Detailed Segmentation:

  • Global Molecular Diagnostics Market, By Product Type:
    • Reagents & Kits (Consumables)
    • Instruments
  • Global Molecular Diagnostics Market, By Application
    • Oncology
    • Genetic Testing
    • Microbiology
    • STDs
    • Blood Screening
    • Virology
    • Tissue Typing
    • Prenatal Diagnosis
    • Others
  • Global Molecular Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Academic and Research Labs
    • Others
  • Global Molecular Diagnostics Market, By Region:
    • North America
      • North America Molecular Diagnostics Market, By Product Type
        • Reagents & Kits (Consumables)
        • Instruments
      • North America Molecular Diagnostics Market, By Application
        • Oncology
        • Genetic Testing
        • Microbiology
        • STDs
        • Blood Screening
        • Virology
        • Tissue Typing
        • Prenatal Diagnosis
        • Others
      • North America Molecular Diagnostics Market, By End User
        • Hospitals
        • Diagnostic Laboratories
        • Academic and Research Labs
        • Other
      • North America Molecular Diagnostics Market, By Country
        • U.S.
        • Canada
    • Europe
      • Europe Molecular Diagnostics Market, By Product Type
      • Europe Molecular Diagnostics Market, By Application
      • Europe Molecular Diagnostics Market, By End User
      • Europe Molecular Diagnostics Market, By Country
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Molecular Diagnostics Market, By Product Type
      • Asia Pacific Molecular Diagnostics Market, By Application
      • Asia Pacific Molecular Diagnostics Market, By End User
      • Asia Pacific Molecular Diagnostics Market, By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Latin America Molecular Diagnostics Market, By Product Type
      • Latin America Molecular Diagnostics Market, By Application
      • Latin America Molecular Diagnostics Market, By End User
      • Latin America Molecular Diagnostics Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Middle East Molecular Diagnostics Market, By Product Type
      • Middle East Molecular Diagnostics Market, By Application
      • Middle East Molecular Diagnostics Market, By End User
      • Middle East Molecular Diagnostics Market, By Country
        • GCC
        • Israel
        • Rest of Middle East
    •  Africa
      • Africa Molecular Diagnostics Market, By Product Type
      • Africa Molecular Diagnostics Market, By Application
      • Africa Molecular Diagnostics Market, By End User
      • Africa Molecular Diagnostics Market, By Country
        • North Africa
        • Central Africa
        • South Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021